---

---

sector : Professional, scientific, and technical services    entities : Novartis ag   

save search

---

Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics
Published: 2023-10-13 (Crawled : 16:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -26.96% | O: -1.86% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -29.58% | O: -2.78% H: 0.04% C: -0.57%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 18.92% | O: -0.21% H: 0.42% C: -1.17%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -3.59% | O: -0.55% H: 0.69% C: -0.09%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.02% | O: 0.64% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 19.36% | O: 1.15% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 12.21% | O: 0.38% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 0.65% | O: -0.59% H: 0.62% C: -0.56%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -5.65% | O: 0.93% H: 0.26% C: -1.25%
management growing

---

Autism Spectrum Disorder Therapeutics Market to Grow by USD 772.65 million from 2022 to 2027 | Increasing prevalence of ASD boosts the market growth - Technavio
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -99.97% | O: -27.59% H: 0.0% C: 0.0%
TVTX | $5.73 -1.21% -1.22% 950K |

Health Technology

| -56.4% | O: 0.69% H: 0.98% C: -0.15%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -8.64% | O: -0.25% H: 0.47% C: -1.08%
JAZZ | $109.96 0.63% 0.63% 760K |

Health Technology

| -22.82% | O: 1.08% H: 1.22% C: 0.92%
therapeutics growth market

---

RNAi Drug Delivery Market worth $109.73 billion between 2022-2027- Exclusive report by Technavio
Published: 2023-07-27 (Crawled : 08:00) - prnewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K |

Professional, Scientific, and T...

| -79.13% | O: 2.57% H: 3.43% C: 0.47%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| -5.16% | O: 0.17% H: 0.35% C: -2.67%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -9.17% | O: 0.7% H: 0.12% C: -0.76%
SLN | $22.75 3.32% 3.21% 310K |

Health Technology

| 322.39% | O: 2.61% H: 0.27% C: -2.18%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -12.74% | O: 0.92% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -18.88% | O: -0.64% H: 0.0% C: 0.0%
BNTC | $6.89 1.03% 1.02% 250K |

Health Technology

| 88.92% | O: -8.92% H: 9.49% C: 0.59%
drug report market

---

Viral Vector Manufacturing Market worth $12.8 billion | MarketsandMarkets
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6 |

Health Technology

| -10.75% | O: 3.47% H: 0.0% C: -2.56%
LZAGY | $55.65 0.02% 32K |

Professional, Scientific, and T...

| -11.62% | O: -0.59% H: 0.02% C: 0.02%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| 5.13% | O: 0.35% H: 0.91% C: 0.71%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.51% | O: -0.16% H: 0.11% C: -0.76%
DHR | $235.51 -0.36% 0.0% 2.3M |

Health Technology

| 0.06% | O: 0.0% H: 1.29% C: 1.14%
CRL | $226.78 -0.34% 0.0% 410K |

Commercial Services

| 14.72% | O: 0.08% H: 5.1% C: 3.86%
BLUE | $1.02 7.03% 6.11% 8.2M |

Health Technology

| -72.05% | O: 1.37% H: 0.29% C: -5.41%
market

---

KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
Published: 2023-06-08 (Crawled : 13:20) - biospace.com/
DAWN 4 | $14.98 -4.89% -5.14% 1.4M |

Professional, Scientific, and T...

| 3.82% | O: -0.69% H: 0.0% C: -7.55%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -4.2% | O: 1.26% H: 1.08% C: 0.91%
KZIA | $0.379 9.47% 8.65% 300K |

Health Technology

| -70.31% | O: 1.57% H: 3.07% C: 1.53%
paxalisib therapeutics study

---

KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
Published: 2023-06-08 (Crawled : 11:00) - prnewswire.com
DAWN 4 | $14.98 -4.89% -5.14% 1.4M |

Professional, Scientific, and T...

| 3.82% | O: -0.69% H: 0.0% C: -7.55%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -4.2% | O: 1.26% H: 1.08% C: 0.91%
KZIA | $0.379 9.47% 8.65% 300K |

Health Technology

| -70.31% | O: 1.57% H: 3.07% C: 1.53%
paxalisib therapeutics study

---

Pulmonary arterial hypertension (PAH) drugs market size to grow by USD 2,080.07 million between 2022 and 2027; Growth driven by growing prevalence of PAH - Technavio
Published: 2023-04-18 (Crawled : 07:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 3.38% | O: -6.76% H: 3.18% C: 1.34%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| -7.21% | O: 2.33% H: 0.7% C: -0.88%
AVTE M | $21.86 1.2% 1.19% 220K |

Professional, Scientific, and T...

| 21.49% | O: 0.0% H: 2.26% C: 1.38%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 13.52% | O: 0.2% H: 0.09% C: -0.5%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -3.68% | O: 0.18% H: 0.11% C: -0.85%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 6.31% | O: -0.64% H: 0.23% C: -1.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -6.9% | O: 2.35% H: 0.62% C: -0.45%
growing hypertension growth market

---

Liver Cancer Drugs Market size to grow at a CAGR of 14.67% from 2021 to 2026, Driven by the growing incidence of liver cancer - Technavio
Published: 2023-04-12 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| -4.59% | O: 5.41% H: 0.0% C: -2.14%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 17.97% | O: 1.1% H: 0.0% C: 0.0%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -99.99% | O: 0.0% H: 3.57% C: 3.57%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -1.5% | O: 0.75% H: 0.5% C: -0.05%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -5.03% | O: 1.96% H: 0.71% C: 0.22%
liver cancer growing market

---

TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 36.78% | O: 2.45% H: 0.0% C: 0.0%
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K |

Professional, Scientific, and T...

| 106.67% | O: -2.73% H: 6.07% C: 3.43%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 12.36% | O: -0.4% H: 0.32% C: -0.42%
year therapeutics financial results

---

Regenerative Medicine Market to be Worth $180.87 Billion by 2030: Grand View Research, Inc.
Published: 2023-02-14 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| -2.21% | O: 0.43% H: 1.52% C: -1.88%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 28.82% | O: 0.34% H: 0.0% C: 0.0%
USRM | $0.0001 1300.0% 290K |

Professional, Scientific, and T...

| -97.78% | O: 2.22% H: 4.35% C: 4.35%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -40.9% | O: 0.23% H: 0.25% C: -0.84%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 7.85% | O: 0.27% H: 0.42% C: -0.21%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 107.28% | O: 0.04% H: 0.93% C: -0.85%
NUVA | $39.75 -2.24% -2.29% 0 |

Health Technology

| -10.15% | O: -0.16% H: 2.24% C: 0.79%
MDXG | $6.3 2.27% 2.22% 690K |

Health Technology

| 36.15% | O: -1.3% H: 2.85% C: 2.19%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -1.66% | O: 0.3% H: 0.94% C: 0.6%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 10.37% | O: -0.39% H: 0.12% C: -0.69%
market

---

Liver cancer drugs market size to grow by USD 5.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
Published: 2023-02-09 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 6.4% | O: 6.07% H: 1.75% C: 0.35%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -99.98% | O: -4.0% H: 4.17% C: 4.17%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 8.6% | O: 0.87% H: 0.17% C: -1.53%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 6.51% | O: 6.13% H: 0.42% C: -1.3%
liver cancer market

---

Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
EMMA | $0.1138 385.44% 300 |

Professional, Scientific, and T...

| -73.4% | O: 33.02% H: 0.0% C: -21.11%
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| 33.97% | O: -5.8% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 10.11% | O: 0.74% H: 0.89% C: 0.53%
DHR | $235.51 -0.36% 0.0% 2.3M |

Health Technology

| -9.65% | O: -0.32% H: 1.21% C: 0.09%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| 3.28% | O: -0.13% H: 1.13% C: 0.14%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 4.7% | O: 1.02% H: 0.0% C: 0.0%
SGMO | $0.5143 6.02% 5.68% 1M |

Health Technology

| -86.03% | O: -1.1% H: 1.66% C: -0.28%
ALNY | $144.315 -0.58% -0.59% 700K |

Health Technology

| -33.56% | O: 0.22% H: 2.19% C: -5.13%
global report market

---

Sickle Cell Disease Treatment Market to Garner USD 1.6 Billion by 2031: Allied Market Research
Published: 2022-11-10 (Crawled : 01:00) - prnewswire.com
EMMA | $0.1138 385.44% 300 |

Professional, Scientific, and T...

| -75.68% | O: -18.92% H: 15.0% C: 15.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 13.73% | O: 2.81% H: 0.43% C: -0.2%
treatment research disease market

---

Global Small-Molecule APIs Market to Reach $38.54 Billion by 2027
Published: 2022-08-19 (Crawled : 12:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6 |

Health Technology

| -7.9% | O: 0.13% H: 0.0% C: -1.85%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 13.24% | O: -1.05% H: 0.0% C: 0.0%
LZAGY | $55.65 0.02% 32K |

Professional, Scientific, and T...

| -7.99% | O: -0.73% H: 0.29% C: -1.26%
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| 24.37% | O: 0.68% H: 0.77% C: -0.38%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 11.12% | O: 0.44% H: 0.63% C: 0.55%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -11.97% | O: -0.61% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 16.06% | O: 0.09% H: 0.61% C: -0.64%
ALB | $112.15 0.31% -0.13% 2M |

Process Industries

| -59.88% | O: -1.28% H: 0.03% C: -2.14%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 17.78% | O: 0.35% H: 1.11% C: 0.05%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 11.54% | O: -0.94% H: 0.0% C: 0.0%
global market

---

LAMEA Peptide Therapeutics Market Report 2022: Annual Growth of 12.5% Expected Through 2028
Published: 2022-08-05 (Crawled : 15:20) - prnewswire.com
LZAGF | $563.5 -19.1% 6 |

Health Technology

| -8.03% | O: -4.5% H: 0.0% C: 0.0%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -2.01% | O: -6.04% H: 2.59% C: 2.59%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -4.85% | O: 3.16% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 2.14% | O: 0.59% H: 0.0% C: -4.45%
LZAGY | $55.65 0.02% 32K |

Professional, Scientific, and T...

| -8.96% | O: -3.78% H: 0.57% C: 0.36%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -4.95% | O: -0.65% H: 0.29% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -47.85% | O: -0.44% H: 0.66% C: -0.75%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 10.71% | O: -0.16% H: 0.71% C: 0.56%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -2.09% | O: -1.26% H: 1.36% C: 1.2%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 137.52% | O: -1.08% H: 0.94% C: -0.38%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.22% | O: -0.32% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 3.41% | O: -0.63% H: 0.63% C: 0.24%
report expected therapeutics growth market

---

U.S. Small-Molecule APIs Market to Reach $7.84 Billion by 2027
Published: 2022-08-03 (Crawled : 11:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6 |

Health Technology

| -10.82% | O: -3.53% H: 0.0% C: 0.0%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -3.23% | O: -1.8% H: 0.2% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -8.03% | O: -2.6% H: 0.0% C: -0.76%
LZAGY | $55.65 0.02% 32K |

Professional, Scientific, and T...

| -8.11% | O: 0.55% H: 0.48% C: 0.36%
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| 30.82% | O: 0.71% H: 1.52% C: 0.71%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 10.93% | O: 0.11% H: 0.31% C: -0.34%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -15.68% | O: -1.64% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.47% | O: -0.29% H: 0.24% C: -0.58%
ALB | $112.15 0.31% -0.13% 2M |

Process Industries

| -54.02% | O: 0.87% H: 0.0% C: -2.63%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 17.83% | O: 0.32% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.59% | O: -0.17% H: 0.12% C: -1.29%
market

---

INVESTOR DEADLINE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN
Published: 2022-07-16 (Crawled : 08:20) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
MOLN | News | $3.74 -3.54% 6.2K |

Professional, Scientific, and T...

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
molecular

---

Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published: 2022-06-21 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 13.29% | O: 6.34% H: 0.0% C: -4.65%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 42.5% | O: 4.65% H: 0.0% C: -4.51%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -100.0% | O: 46.85% H: 0.0% C: -30.95%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 15.79% | O: 1.41% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 11.99% | O: 2.03% H: 0.0% C: 0.0%
research liver cancer market

---

Liver Cancer Drugs Market - 42% of Growth to Originate from North America | Evolving Opportunities with AstraZeneca Plc & Bayer AG| 17000+ Technavio Reports
Published: 2022-03-30 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 0.07% | O: -5.22% H: 6.2% C: 1.91%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -100.0% | O: 0.0% H: 0.0% C: -15.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 7.83% | O: 0.58% H: 0.56% C: -0.07%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 3.94% | O: 0.42% H: 1.49% C: 1.34%
america liver cancer growth market

---

Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
Published: 2022-03-15 (Crawled : 21:00) - globenewswire.com
MOLN | News | $3.74 -3.54% 6.2K |

Professional, Scientific, and T...

| -83.81% | O: -0.2% H: 0.24% C: -0.46%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 15.32% | O: 2.25% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 12.01% | O: 0.74% H: 0.0% C: 0.0%
als report molecular

---

Gainers vs Losers

67%

33%

Top 10 Gainers

---

Your saved searches

---